About the Company
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.
Sector
Industrial Applications and Services
Industry
Laboratory Analytical Instruments
Employees
8120
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BIO News
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
Bio-Rad Laboratories, Inc. BIO is expected to release first-quarter 2024 results on May 2 after the closing bell. The company ...
BIO.B Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...
S&P 500 (SPX) today: Top movers are Bio-Rad Laboratories Inc and Agilent Technologies, Inc.
The S&P 500 opened today at 5,028.85. Within 30 minutes of trading, the benchmark index rose by 18.66 points, or 0.37%.
Bio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week, taking three-year losses to 53%
Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position ...
Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through ...
Commit To Purchase Bio-Rad Laboratories At $185, Earn 1.3% Annualized Using Options
Investors considering a purchase of Bio-Rad Laboratories Inc (Symbol: BIO) shares, but cautious about paying the going market price of $293.00/share, might benefit from considering selling puts ...
Bio-Rad announces collaboration agreement with oncocyte to commercialize transplant monitoring with droplet digital PCR
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) a global leader in life science research and clinical diagnostics products, ...
Bio-Rad launches first ultrasensitive multiplexed digital PCR assay for breast cancer mutation detection in clinical research
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay ...
Bio-Rad Laboratories Inc. Cl B
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...